These results suggested that motor severity scores increased over time; that higher GRS-PD was associated with lower motor severity scores given the same levels of time-varying CSF biomarkers and the same levels of CSF biomarkers and DAT-putamen. Here, SLC6A3 is linked to Parkinson disease.